Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Citation: Boominathan, Inerleukin-based therapy for cancer: Resistin suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 20/October/2014, 6.49 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Courtesy: When you cite drop us a line at email@example.com
Significance: This study suggests that Resistin, by increasing the expression of its target gene, it may suppress the expression of Notch1 and Notch2. Thus, pharmacological formulations encompassing “Resistin activators“ may be used to inhibit tumorigenesis and metastasis.